Table 2 Association between nutrient supplementation and the rate of change in antibody levels
| Â | Rate of change in antibody levels (Percentage antibody level change per gestation week, arbitrary units) | |||||
|---|---|---|---|---|---|---|
|  | LNS (n = 337) compared to IFA (n = 325) | LNS (n = 337) compared to MMN (n = 347) | ||||
| Â | Unadjusted | Adjusted | Adjusted p-value | Unadjusted | Adjusted | Adjusted p-value |
IgG to placental-binding isolate VSA | −0.12 (−0.34, 0.11) | −0.08 (−0.38, 0.22) | 0.599 | 0.13 (−0.09, 0.36) | 0.26 (−0.04, 0.55) | 0.089 |
Opsonizing antibodies to placental-binding solate VSA | −0.02 (−0.24, 0.19) | −0.11 (−0.41, 0.19) | 0.469 | 0.06 (−0.14, 0.27) | 0.02 (−0.26, 0.30) | 0.864 |
Opsonizing antibodies to non-placental-binding isolate VSA | −0.002 (−0.12, 0.12) | 0.01 (−0.16, 0.18) | 0.888 | −0.08 (−0.19, 0.03) | 0.02 (−0.13, 0.18) | 0.756 |
MSP-1 19kD | −0.02 (−0.17, 0.12) | 0.006 (−0.18, 0.19) | 0.953 | −0.06 (−0.19, 0.08) | 0.04 (−0.14, 0.21) | 0.693 |
MSP-2 | −0.12 (−0.27, 0.03) | −0.20 (−0.40, 0.02) | 0.069 | −0.15 (−0.32, 0.01) | −0.25 (−0.46, −0.04)* | 0.021* |
MSP-3 | −0.18 (−0.36, −0.01)* | −0.21 (−0.44, 0.03) | 0.080 | −0.05 (−0.24, 0.14) | −0.01 (−0.28, 0.27) | 0.970 |
PfRh2 | 0.07 (−0.13, 0.27) | 0.10 (−0.17, 0.37) | 0.461 | −0.21 (−0.40, −0.02)* | −0.25 (−0.51, 0.02) | 0.073 |
EBA-175 | −0.06 (−0.18, 0.06) | −0.04 (−0.20, 0.13) | 0.639 | −0.07 (−0.20, 0.05) | −0.05 (−0.24, 0.14) | 0.603 |
Schizont extract | −0.03 (−0.28, 0.23) | 0.13 (−0.21, 0.48) | 0.450 | 0.003 (−0.26, 0.27) | 0.10 (−0.26, 0.47) | 0.583 |